Your browser doesn't support javascript.
loading
[Neoplastic angiogenesis]. / Angiogénesis neoplásica.
Khosravi Shahi, P; Castillo Rueda, A Del; Pérez Manga, G.
  • Khosravi Shahi P; Servicio de Oncología Médica, Hospital General Universitario Gregorio Marañón, Madrid, España. drkhosravi@hotmail.com
An Med Interna ; 25(7): 366-9, 2008 Jul.
Article en Es | MEDLINE | ID: mdl-19296000
ABSTRACT
Neoplastic angiogenesis is an essential process in the progressive growth of neoplasms and the production of metastasis. Angiogenesis consists of a series of linked and sequential steps that ultimately leads to the development of a neovascular blood supply to the tumor mass. VEGF has got an essential role in neoplastic angiogenesis, therefore it is an important target in the treatment of neoplasms. Bevacizumab, a humanized monoclonal antibody, inhibits VEGF, and may also improve the delivery of chemotherapy to the tumor mass. Multi-kinase ihibitors (sorafenib and sunitinib) are orally administered small-molecules, that inhibit different receptors (essentials in the neoplastic angiogenesis), such as the VEGFR or PDGFR. These agents are useful in the treatment of advanced renal-cell carcinoma, and are under investigation in several tumors.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Límite: Humans Idioma: Es Año: 2008 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Límite: Humans Idioma: Es Año: 2008 Tipo del documento: Article